HLA
CPXX

Hamilton Lane Advisors’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Hamilton Lane Advisors’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-17,280
Closed -$51K – 78
2014
Q2 		$51K Buy
+17,280
New +$47.6K 0.02% 55

Other funds holding CPXX

CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
CPA
Cowen Prime Advisors New York $290M AUM 57.8% 1-Year Est. Return
SIM
Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MA
MUFG Americas New York $4.04B AUM 12.45% 1-Year Est. Return

Hamilton Lane Advisors's CPXX Position: Q3 2014 in Review

Hamilton Lane Advisors sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2014, closing a stake of 17,280 shares — an estimated $51K sold.

Hamilton Lane Advisors first reported a position in CPXX in Q2 2014 and held it in 1 quarter. The position peaked at $51K in Q2 2014. 13 funds tracked by Wall St. Rank hold CPXX as of Q3 2014.

  • Hamilton Lane Advisors reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2014 after selling out during the quarter.
  • Hamilton Lane Advisors sold 17,280 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2014, an estimated $51K.
  • Hamilton Lane Advisors first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2014 and held it in 1 quarter.
  • Hamilton Lane Advisors's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $51K in Q2 2014.
  • 13 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2014.

Based on Hamilton Lane Advisors's 13F filing for Q3 2014, filed 6 Oct 2014.